Appeal No. 2000-1919 Application No. 08/831,993 Answer, page 6 (emphasis in original). We have reviewed the cited references, however, and we do not find that they provide evidence to support the examiner’s conclusion. Gwadz states that “[i]n vitro studies . . . showed that the magainin peptide could disrupt extracellular stages of [plasmodial] parasites but that it had no effect on intracellular development.” Page 2628, right-hand column. However, Gwadz provides no evidence to support this conclusion, citing only “unpublished data.” Id. The Matsuzaki references cited by the examiner also do not support his position. Matsuzaki investigated the molecular basis of the effect of magainins on different membranes and the translocation of magainin peptides from one side of a membrane to the other. The examiner has not adequately explained how either Matsuzaki reference contradicts the data in the instant specification or shows that magainins do not penetrate inside cells. Appellant’s position, on the other hand, is supported by the working examples in the specification. The examiner has complained that the presentation of the data in the specification makes it difficult for him to independently evaluate whether they support the specification’s conclusions. However, “a specification disclosure which contains a teaching of the manner and process of making and using the invention in terms which correspond in scope to those used in describing and defining the subject matter sought to be patented must be taken as in compliance with the enabling requirement of the first paragraph of § 112 unless there is reason to doubt the objective truth of the statements contained therein which must be relied on for enabling support.” 7Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007